Louis D Saravolatz Selected Research

Louis D Saravolatz Research Topics

Disease

11	Infections 12/2022 - 02/2006
4	Osteomyelitis 10/2019 - 08/2015
3	Nausea 10/2019 - 04/2009
3	Bacteremia 07/2011 - 06/2003
2	Bacterial Pneumonia 04/2024 - 05/2011
2	COVID-19 01/2023 - 11/2021
2	Sepsis (Septicemia) 01/2021 - 05/2012
2	Diarrhea 10/2019 - 04/2005
2	Vomiting 10/2019 - 12/2009
2	Endocarditis 01/2019 - 06/2007
2	HIV Infections (HIV Infection) 01/2014 - 04/2009
2	Renal Insufficiency (Renal Failure) 05/2011 - 12/2009
2	Exanthema (Rash) 04/2009 - 11/2003
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2003 - 09/2003
1	Lung Injury 11/2021
1	Critical Illness (Critically Ill) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Human Influenza (Influenza) 10/2020
1	Taste Disorders (Taste Disorder) 10/2019
1	Cysts 01/2018
1	Ventilator-Associated Pneumonia 01/2017
1	Torsades de Pointes (Torsade de Pointes) 02/2013
1	Infectious Arthritis (Septic Arthritis) 04/2011
1	Hypoxia (Hypoxemia) 08/2010
1	Ischemia 08/2010
1	Pruritus (Itching) 12/2009
1	Dysgeusia (Parageusia) 12/2009
1	Pneumonia (Pneumonitis) 12/2009
1	Myocardial Infarction 03/2008
1	Infarction (Infarctions) 03/2008
1	Communicable Diseases (Infectious Diseases) 11/2006
1	Phototoxic Dermatitis (Phototoxicity) 11/2003
1	Sinusitis 11/2003
1	Meningitis 01/2003

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 07/2018 - 09/2003
4	Vancomycin FDA LinkGeneric 12/2022 - 12/2009
4	telavancin FDA Link 12/2019 - 12/2009
2	Antiviral Agents (Antivirals)IBA 01/2023 - 10/2020
2	Ceftaroline FDA Link 12/2022 - 05/2011
2	LipoglycopeptidesIBA 08/2015 - 12/2009
1	AlbuminsIBA 04/2024
1	molnupiravirIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Daptomycin FDA Link 12/2022
1	Fosfomycin FDA Link 12/2022
1	Linezolid (Zyvox)FDA Link 12/2022
1	Anti-Infective Agents (Microbicides)IBA 12/2022
1	tocilizumab (atlizumab)FDA Link 11/2021
1	Particulate MatterIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	baloxavirIBA 10/2020
1	Neuraminidase (Sialidase)IBA 10/2020
1	Methicillin (Metin)FDA Link 10/2019
1	CoagulaseIBA 10/2019
1	FluoroquinolonesIBA 01/2019
1	EnzymesIBA 08/2015
1	oritavancinIBA 08/2015
1	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine Cobicistat ElvitegravirIBA 01/2014
1	Rilpivirine (TMC-278)IBA 02/2013
1	Polyvinyl Chloride (PVC)IBA 05/2012
1	Culture MediaIBA 07/2011
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 05/2011
1	ProdrugsIBA 05/2011
1	SYBR Green IIBA 04/2011
1	Ribosomal DNA (rDNA)IBA 04/2011
1	UrocortinsIBA 08/2010
1	Caspase 3 (Caspase-3)IBA 08/2010
1	Reverse Transcriptase InhibitorsIBA 04/2009
1	etravirine (TMC-125)FDA Link 04/2009
1	Glyburide (Glibenclamide)FDA LinkGeneric 03/2008
1	HirudinsIBA 03/2008
1	thrombin receptor peptide SFLLRNPIBA 03/2008
1	Thrombin Receptors (Thrombin Receptor)IBA 03/2008
1	Panton-Valentine leukocidinIBA 10/2006
1	nitazoxanide (NTZ)FDA Link 04/2005
1	beta-LactamsIBA 11/2003
1	Gatifloxacin (Zymar)FDA Link 11/2003
1	Moxifloxacin (Avelox)FDA Link 11/2003
1	Gemifloxacin (Factive)FDA Link 11/2003

Therapy/Procedure

9	Therapeutics 12/2022 - 01/2003
1	Ligation 03/2008
1	Renal Dialysis (Hemodialysis) 06/2007
1	Long-Term Care 06/2003